학술논문

E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Document Type
Artikel
Source
Molecular oncology. 16(12):2312-2329
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1878-0261